NSPR - InspireMD, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 55.03M
Enterprise Value 3250.75k
Trailing P/E N/A
Forward P/E 12.40
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.67
Price/Book (mrq)0.56
Enterprise Value/Revenue 30.08
Enterprise Value/EBITDA 6-0.03

Trading Information

Stock Price History

Beta (3Y Monthly) 3.49
52-Week Change 3-90.67%
S&P500 52-Week Change 38.07%
52 Week High 344.0000
52 Week Low 33.0000
50-Day Moving Average 33.6383
200-Day Moving Average 36.6010

Share Statistics

Avg Vol (3 month) 3282.26k
Avg Vol (10 day) 324.07k
Shares Outstanding 51.4M
Float 1.01M
% Held by Insiders 16.79%
% Held by Institutions 118.45%
Shares Short (May 31, 2019) 4188.68k
Short Ratio (May 31, 2019) 40.38
Short % of Float (May 31, 2019) 424.53%
Short % of Shares Outstanding (May 31, 2019) 413.50%
Shares Short (prior month Apr 30, 2019) 485.32k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 250/1
Last Split Date 3Apr 1, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -267.80%
Operating Margin (ttm)-292.06%

Management Effectiveness

Return on Assets (ttm)-63.34%
Return on Equity (ttm)-190.43%

Income Statement

Revenue (ttm)3.01M
Revenue Per Share (ttm)4.56
Quarterly Revenue Growth (yoy)-58.80%
Gross Profit (ttm)995k
EBITDA -8.64M
Net Income Avi to Common (ttm)-8.46M
Diluted EPS (ttm)-12.8230
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.81M
Total Cash Per Share (mrq)4.16
Total Debt (mrq)1.14M
Total Debt/Equity (mrq)20.18
Current Ratio (mrq)3.02
Book Value Per Share (mrq)6.47

Cash Flow Statement

Operating Cash Flow (ttm)-9.31M
Levered Free Cash Flow (ttm)-6.26M